natgillin/translations-raw huggingface dataset:
This is especially important if you are taking: medicines to treat an infection caused by a parasite, as Xolair may reduce the effect of your medicines, inhaled corticosteroids and other medicines for allergic asthma.
To je posebno pomembno, če jemljete: zdravila za zdravljenje okužb, ki jih povzročajo paraziti (zajedavci), saj zdravilo Xolair lahko oslabi delovanje vaših zdravil, kortikosteroide za inhaliranje in druga zdravila proti alergijski astmi.
This is especially important if you are taking: other medicines for rheumatoid arthritis such as antimalarials (e.g. chloroquine and hydroxychloroquine), intramuscular or oral gold, D-penicillamine, azathioprine and other immunosuppressive drugs (e.g. methotrexate) as these combinations are not advisable,
To je še posebej pomembno, če jemljete: druga zdravila za zdravljenje revmatoidnega artritisa, kot so antimalariki (npr. klorokin in hidroksiklorokin), intramuskularno ali peroralno dano zlato, D-penicilamin, azatioprin in druga imunosupresivna zdravila (npr. metotreksat), saj te kombinacije niso priporočljive,
This is especially important if you are taking: other medicines for rheumatoid arthritis such as antimalarials (e.g. chloroquine and hydroxychloroquine), intramuscular or oral gold, D-penicillamine, azathioprine and other immunosuppressive medicines (e.g. methotrexate) as these combinations are not advisable,
To je še posebej pomembno, če jemljete: druga zdravila za zdravljenje revmatoidnega artritisa, kot so antimalariki (npr. klorokin in hidroksiklorokin), intramuskularno ali peroralno dano zlato, D-penicilamin, azatioprin in druga imunosupresivna zdravila (npr. metotreksat), saj te kombinacije niso priporočljive,
This is especially important if you take medicines to treat heart problems or if you are taking any medicine which can cause an abnormality on the ECG (electrocardiogram) called increased PR interval including carbamazepine, lamotrigine, pregabalin (medicines used to treat epilepsy) and medicines used to treat certain types of irregular heart beat or heart failure.
To je še posebno pomembno, če jemljete zdravila za zdravljenje težav s srcem ali če jemljete katero koli zdravilo, ki lahko povzroči nenormalnosti EKG (elektrokardiogram), ki podaljšajo interval P-R vključno s karbamazepinom, lamotriginom, pregabalinom (zdravila za zdravljenje epilepsije) in zdravila, ki se uporabljajo za zdravljenje določenih vrst nepravilnega bitja srca ali srčnega popuščanja.
This is especially important within the first 14 days of treatment (see more information in “How to take Nevirapine Teva”).
To je še posebej pomembno prvih 14 dni zdravljenja (glejte podrobnejše informacije v odstavku »Kako jemati Nevirapin Teva«).
This is especially important within the first 14 days of treatment (see more information in “How to take Viramune”).
To je še posebej pomembno prvih 14 dni zdravljenja (glejte podrobnejše informacije v odstavku »Kako jemati zdravilo Viramune«).
This is explained by completed dabigatran absorption after 2 hours (see section 4.4).
To lahko pojasnimo z dokončano absorpcijo dabigatrana po 2 urah (glejte poglavje 4.4).
This is explained by completed dabigatran absorption after 2 hours (see section 4.4).
To razloži dokončana absorbcije dabigatrana po 2 urah (glejte poglavje 4.4).
This is followed by a dose of 420 mg every three weeks given over a period of half an hour to one hour.
Temu sledi 420-miligramski odmerek vsake tri tedne s 30-minutno do enourno infuzijo.
This is followed by a gap of four to five weeks, after which the patient is given an infusion of 2,000 mg once a month for four months.
Temu sledi premor štirih do petih tednov, nato pa bolnik prejema 2 000-miligramsko infuzijo štiri mesece enkrat mesečno.
This is followed by a maintenance dose of 200 mg every 2 weeks (from week 6) or 400 mg every 4 weeks (from week 8) as instructed by your physician.
Sledi vzdrževalni odmerek 200 mg vsak drugi teden (po 6 tednih) ali 400 mg vsake 4 tedne (po 8 tednih) po navodilih zdravnika.
This is followed by a second treatment with 25 mg tylvalosin per kg bodyweight per day in drinking water for 3 consecutive days at the period of risk, i.e. at times of management stress such as administration of vaccines (typically when birds are 2–3 weeks old).
Temu sledi drugo zdravljenje s 25 mg tilvalozina na kg telesne teže na dan v vodi za pitje 3 zaporedne dni v obdobju tveganja, t.j. v času stresa zaradi vzrejnih postopkov, na primer ob cepljenjih (navadno takrat, ko so ptice stare 2-3 tedne).
This is followed by a second treatment with 25 mg tylvalosin per kg bodyweight per day in drinking water for 3 consecutive days at the period of risk, i.e. at times of management stress such as administration of vaccines (typically when birds are 2–3 weeks old).
Temu sledi drugo zdravljenje s 25 mg tilvalozina na kg telesne teže na dan v vodi za pitje 3 zaporedne dni v obdobju tveganja, t.j. v času stresa zaradi vzrejnih postopkov, na primer ob cepljenju (navadno takrat, ko so ptice stare 2-3 tedne).
This is followed by the fibrinogen- thrombin reaction which initiates the last phase of physiological blood coagulation.
Temu sledi fibrinogensko-trombinska reakcija, ki sproži zadnjo fazo fiziološke koagulacije krvi.
This is found on the surface of most leucocytes (the white cells in the blood that are involved in the inflammation process).
Ta se nahaja na površini večine levkocitov (belih krvnih celic v krvi, ki sodelujejo pri vnetju).
This is further supported by data in children given similar seasonal and pandemic live attenuated flu vaccines in large studies and in clinical practice.
To pričakovanje podpirajo tudi podatki iz velikih študij in klinične prakse o delovanju podobnih sezonskih in pandemskih živih oslabljenih cepiv proti gripi pri otrocih.
This is generally done on a case-by-case basis.
O tovrstnem zdravljenju se odloča za vsak primer posebej.
This is generally reversible and will usually disappear within two weeks.
To je običajno reverzibilno in po dveh tednih navadno izgine.
This is given 2 times a week by injection into a vein.
Daje se ga dvakrat tedensko z injekcijo v veno.
This is given as a 1 ml injection just below the skin.
To damo kot 1-ml injekcijo tik pod kožo.
this is given once every 3 weeks the medicine “cyclophosphamide” is given on the same day.
zdravilo se daje enkrat na vsake 3 tedne; zdravilo s ciklofosfamidom se daje na isti dan.
This is given three times a week, injected into a vein (over 1-5 minutes).
Daje se trikrat tedensko kot injekcijo v veno (v času 1-5 minut).
This is important as Alisade is a thick suspension that becomes liquid when you shake it well - see picture b.
To je pomembno, kajti zdravilo Alisade je gosta suspenzija, ki postane tekoča, ko jo dobro pretresete – glejte sliko b.
This is important as Avamys is a thick suspension that becomes liquid when you shake it well - see picture b.
To je pomembno, kajti zdravilo Avamys je gosta suspenzija, ki postane tekoča, ko jo dobro pretresete – glejte sliko b.
This is important because Baraclude is eliminated from your body through the kidneys and your dose or dosing schedule may need to be adjusted.
To je pomembno, ker se zdravilo Baraclude iz telesa izloča skozi ledvice in vam bo zdravnik morda moral odmerek ali odmerno shemo prilagoditi.
This is important because ZYTIGA may increase the effects of a number of medicines including heart medicines, tranquilizers, herbal medicines (e.g., St John’s wort) and others.
To je pomembno, ker lahko zdravilo ZYTIGA poveča učinek številnih zdravil, vključno z zdravili za zdravljenje srčnih bolezni, pomirjeval, zdravil rastlinskega izvora (npr. šentjanževka) in drugih zdravil.
This is important to ensure the ulcer heals as quickly and completely as possible, and to remove any REGRANEX gel from the previous application.
To je pomembno, saj tako zagotovite hitro in čimbolj popolno celjenje razjede ter hkrati z nje odstranite ostanke REGRANEX gela od prejšnjega nanosa.
This is important to get the right levels of active substance in your body.
To je pomembno, da dobite pravilne ravni zdravilne učinkovine v telo.
This is in addition to the educational material which all potential users should receive.
Prejeti mora tudi izobraževalni material, ki ga morajo prejeti vsi možni uporabniki.
This is in line with the results of the in vitro tests in which no meaningful CYP induction or inhibition by safinamide was observed and it was shown that CYP enzymes play a minor role in the biotransformation of safinamide (see section 5.2)
To je skladno z rezultati testov in vitro, kjer niso opazili pomembne indukcije ali inhibicije CYP s safinamidom in so dokazali, da encimi CYP nimajo pomembnejše vloge pri biotransformaciji safinamida (glejte poglavje 5.2).
This is in order to further characterise the long term safety profile of pirfenidone based on the important identified, potential risks and missing information as detailed in the Esbriet Risk Management Plan.
To je namenjeno nadaljnji določitvi dolgoročnega varnostnega profila pirfenidona na podlagi ugotovljenih in možnih tveganj ter manjkajočih informacij, kot je opredeljeno v načrtu za obvladovanje tveganj pri zdravilu Esbriet.
This is increased to one 10 mg tablet once a day (10 mg) in the second week and to 1 and a half 10 mg tablets once a day in the third week.
V drugem tednu odmerek povišamo na eno 10-miligramsko tableto enkrat na dan (10 mg) in v tretjem tednu na eno tableto 10-miligramsko tableto in pol enkrat na dan.
This is increased to one tablet once a day (1 x 10 mg) in the second week and to 1 and a half tablets once a day (1 x 15 mg) in the third week.
V drugem tednu odmerek povečamo na eno tableto enkrat na dan (1 x 10 mg) in v tretjem tednu na eno tableto in pol enkrat na dan (1 x 15 mg).
This is increased to one tablet once a day (1 x 10 mg) in the second week and to 1and a half tablet once a day (1 x 15 mg) in the third week.
V drugem tednu povišamo odmerek na eno tableto enkrat dnevno (1 x 10 mg) in v tretjem tednu na 1 in ½ tablete enkrat dnevno (1 x 15 mg).
This is increased to one tablet once a day (1x 10 mg) in the second week and to 1 and a half tablets once a day (1x 15 mg) in the third week.
V drugem tednu povišamo odmerek na eno tableto enkrat dnevno (1x10 mg) in v tretjem tednu na 1 tableto in pol (1x15 mg) enkrat dnevno.
This is indicated by a ‘P’ in the display.
To je označeno z oznako »P« na zaslonu.
This is indicative of target mediated drug disposition (TMDD), where the initial abundance of CD20 cells causes a rapid removal of obinutuzumab from the circulation.
To kaže na ciljno posredovano odstranjevanje zdravila (target mediated drug disposition – TMDD), pri katerem začetna količina CD20+ celic povzroči hitro odstranjevanje obinutuzumaba iz obtoka.
This is just in case any of them interfere with how Zebinix works or how Zebinix interferes with their effect.
To je samo opozorilo, če bi katerokoli od njih motilo delovanje zdravila Zebinix ali če bi zdravilo Zebinix vplivalo na njihov učinek.
This is known as a subcutaneous (SC) injection.
Temu se reče subkutano injiciranje.
This is known as ‘empirical treatment’, which means that the doctor starts treatment based on an observation of the patient before confirming that the patient has the infection.
Temu pravimo „empirično zdravljenje“, kar pomeni, da se zdravljenje začne na podlagi opazovanja bolnika, preden lahko zdravnik potrdi, da je bolnik okužen.
This is likely to be the easiest ct if you are doing it yourself.
V tem predelu je samoinjiciranje verjetno najpreprostejše.
This is linked to the way your medicine works as it prevents the ability of blood clots to form.
To je povezano z delovanjem zdravila, saj preprečuje nastanek krvnih strdkov.
This is linked to the way your medicine works as it prevents the ability of blood clots to form.
To je povezano z načinom delovanja zdravila, saj le to preprečuje strjevanje krvi.
This is more common in people whose kidneys are not working properly.
Pogosteje se pojavlja pri osebah z motnjami ledvičnega delovanja.
This is more common in people whose kidneys are not working properly.
To je pogosteje pri ljudeh z okvaro ledvic.
This is more likely to happen if you also take a sulfonylurea or a basal insulin.
Pojav teh opozorilnih znakov je bolj verjeten, če uporabljate tudi sulfonilsečnino ali bazalni insulin.
This is more likely to happen in people with kidney problems or diabetes.
Tovrstne težave se pogosteje pojavijo pri bolnikih z motnjami delovanja ledvic ali s sladkorno boleznijo.
This is more marked in fasting state than in fed state.
To je bolj izrazito pri jemanju rivaroksabana na tešče kot skupaj s hrano.
This is most likely due to induction of CYP3A4 by bosentan.
To je najverjetneje posledicaindukcije CYP3A4 z bosentanom.
This is most likely to occur within 4 hours post sildenafil dosing (see sections 4.2 and 4.4).
Največja verjetnost, da se to zgodi, je v 4 urah po odmerku sildenafila (glejte poglavji 4.2 and 4.4).
This is normal and resolves spontaneously.
To je normalen pojav in spontano mine.
This is normal and will generally resolve within a couple of days.
To je normalno in se navadno razreši v nekaj dneh.
This is normal and will generally resolve within a few days after administration, though may persist longer on rare occasions.
To je normalno in izgine v nekaj dneh po dajanju, v redkih primerih se lahko obdrži dlje.
This is normal.
To je povsem normalno.
This is normal.
To ni nič neobičajnega.
This is not a complete list; please consult the SmPC of the co-administered medicinal product.
To ni celoten seznam; prosimo, glejte povzetke glavnih značilnosti zdravil, ki se uporabljajo sočasno.
THIS IS NOT A DAILY NSAID.
TO NESTEROIDNO PROTIVNETNO ZDRAVILO NI ZA DNEVNO UPORABO.
This is not a sign of intoxication and disappears within some minutes without treatment.
To ni znak zastrupitve, psi se po nekaj minutah nehajo sliniti, ne da bi jih zdravili.
This is not likely to be relevant for humans given recommended doses.
Ta izsledek se verjetno ni relevanten na ljudi, ki jemljejo priporočene odmerke zdravila.
This is not likely to be relevant for humans given recommended doses.
Ta izsledek verjetno ni relevanten na ljudi, ki jemljejo priporočene odmerke zdravila.
This is not necessary, but it may help you keep the pre-filled pen steady and firm against your skin.
To ni potrebno, morda pa vam bo pomagalo, da boste napolnjeni peresnik držali bolj mirno in trdno na koži.
This is not observed in mice or monkeys.
Pri miših ali opicah tega niso opazili.
This is not supplied within the box.
Ta ni dostavljen v škatli.
This is not unusual for proteinaceous solutions.
Za beljakovinski raztopine to ni neobičajno.
This is of importance particularly when changing the laboratory and/or reagents used.
To je zlasti pomembno pri menjavi laboratorija in/ali uporabljenih reagentov.
This is of particular importance because Coxiella burnetii can lead to a disease in humans called Q- fever and decreasing the disease in animals will decrease the likelihood of transmitting the disease to humans.
To je zlasti pomembno, saj lahko bakterija Coxiella burnetii pri ljudeh povzroči bolezen, imenovano mrzlica Q, z zmanjšanjem okužbe pri živalih pa se bo zmanjšala tudi verjetnost, da bi se bolezen prenesla na ljudi.
This is part of a multipack and not for sale of individual vials
To je del pakiranja z vec vialami in ni namenjen za prodajo posameznih vial.
This is part of a multipack of 10 pens and not for sale as individual pens
To je del skupnega pakiranja 10 injekcijskih peresnikov in ni namenjeno za izdajanje posameznih injekcijskih peresnikov
This is part of a multipack of 10 pens and not for sale as individual pens
To je del skupnega pakiranja in ni namenjeno izdajanju posameznih injekcijskih peresnikov.
This is particularly after a therapy to remove Helicobacter pylori.
To še posebej velja za terapijo za odstranitev Helicobacter pylori.
This is particularly important if you are already taking any medicine to treat a heart condition or problems with your blood sugar, kidneys or blood pressure such as medicines containing
To je še posebej pomembno, če že jemljete katero od zdravil za zdravljenje bolezni srca ali težav s krvnim sladkorjem, z ledvicami ali s krvnim tlakom, kot so zdravila, ki vsebujejo:
This is particularly important if you are taking any of the following as your doctor may need to adjust your dose of Emselex and/or the other product:
To je še posebno pomemebno, če jemljete katero od naslednjih zdravil, saj vam bo morda moral zdravnik spremeniti odmerek zdravila Emselex in/ali odmerek drugega zdravila:
This is particularly important in children under the age of 2 years (see ‘Do not use Mirvaso’).
To pa je še posebej pomembno pri otrocih, starih manj kot 2 leti (glejte poglavje „Ne uporabljajte zdravila Mirvaso“).
This is particularly important:
To je pomembno zlasti:
This is particularly significant if these are accompanied by either of the following symptoms:
To je posebej značilno, če se ob tem pojavi kateri od naslednjih simptomov:
This is particularly suitable if:
Posebno primerna je, če:
This is partly related to lower body weight.
50 %, kar je deloma povezano z manjšo telesno maso.
This is recommended to be performed every 6 months.
To je priporočljivo izvajati vsakih 6 mesecev.
This is regarded as a significant improvement in the diagnosis of patients with memory problems who are being evaluated for Alzheimer’s disease and other neurodegenerative diseases.
To ocenjujemo kot bistveno izboljšavo diagnostike bolnikov, ki imajo težave s spominom in pri katerih ugotavljamo morebitno Alzheimerjevo bolezen in druge nevrodegenerativne bolezni.
This is regarded as a significant improvement in the diagnosis of patients with memory problems who are being evaluated for Alzheimer’s disease and other types of dementia.
To se ocenjuje kot pomemben napredek pri diagnosticiranju bolnikov, ki imajo težave s spominom in pri katerih se ugotavlja morebitna Alzheimerjeva bolezen ali druge oblike demence.
This is seen in the following table:
To prikazuje naslednja preglednica:
This is shown in Picture 3 at the beginning of these instructions.
Opisano prikazuje slika 3 na začetku tega navodila.
This is similar to a response rate of 78% observed in patients with wild-type RAS given Vectibix with FOLFOX.
Ta rezultat je podoben stopnji odziva 78 %, opažen v študiji pri bolnikih z divjim tipom gena RAS, ki so prejemali zdravilo Vectibix in kemoterapijo FOLFOX.
This is so your doctor can: decide if you should take ZEPATIER and for how long decide what other medicines you should take with ZEPATIER and for how long
To mu bo omogočilo: da se odloči, ali morate jemati zdravilo ZEPATIER in koliko časa, da se odloči, katera druga zdravila morate jemati skupaj z zdravilom ZEPATIER in koliko časa,
This is sometimes called insulin-dependent diabetes
Ta bolezen se včasih imenuje od insulina odvisna sladkorna bolezen.
This is suitable for younger children and babies: they usually need a Tamiflu dose of less than 30 mg.
Takšna priprava je primerna za mlajše otroke in dojenčke: ponavadi potrebujejo odmerke zdravila Tamiflu, ki so manjši od 30 mg.
This is suitable for younger children and babies: they usually need an Ebilfumin dose of less than 30 mg.
To je običajno primerno za mlajše otroke in dojenčke, ki potrebujejo odmerek zdravila Ebilfumin manjši od 30 mg.
This is suitable for younger, lighter children and babies: they usually need a Tamiflu dose of less than 45 mg.
Takšna priprava je primerna za mlajše otroke in dojenčke: ponavadi potrebujejo odmerke zdravila Tamiflu, ki so manjši od 45 mg.
This is suitable for younger, lighter children and babies: they usually need an Ebilfumin dose of less than 45 mg.
To je običajno primerno za mlajše, lažje otroke in dojenčke, ki potrebujejo odmerek zdravila Ebilfumin manjši od 45 mg.
This is supported by 96 week data from an open-label, randomized and active- controlled study FLAMINGO (ING114915) and additional data from the open-label phase of SINGLE to 144 weeks.
To potrjujejo 96-tedenski podatki odprte, randomizirane, z zdravilno učinkovino kontrolirane študije FLAMINGO (ING114915) in dodatni podatki odprte faze študije SINGLE do 144. tedna.
This is the basis of caffeine’s effect in apnoea of prematurity, for which several mechanisms have been proposed for its actions including: (1) respiratory centre stimulation, (2) increased minute ventilation, (3) decreased threshold to hypercapnia, (4) increased response to hypercapnia, (5) increased skeletal muscle tone, (6) decreased diaphragmatic fatigue, (7) increased metabolic rate, and (8) increased oxygen consumption.
To je osnova učinkovanja kofeina pri apneji zaradi nezrelosti s številnimi predlaganimi mehanizmi za ta način delovanja, vključno s/z: (1) spodbujanjem dihalnega centra, (2) zvišanjem vdihov na minuto, (3) znižanjem praga za hiperkapnijo, (4) zvišanjem odziva na hiperkapnijo, (5) zvišanjem skeletnega mišičnega tonusa, (6) znižanjem diafragmatične utrujenosti, (7) povečanjem hitrosti presnove in (8) zvišano poraba kisika.
This is the case if the biopsy is not good enough to make Holoclar, the cells cannot be grown in the laboratory or the grown cells do not meet all the quality requirements.
To se lahko zgodi v primeru, ko odvzeti delec očesnega tkiva ni dovolj dober za izdelavo zdravila Holoclar, pa tudi ko celic v laboratoriju ni mogoče vzgojiti, ali če vzgojene celice ne izpolnjujejo vseh zahtev po kakovosti.
This is the case if:
Marketing Authorisation Suspended
This is the first biological function to be described for the Hco-MPTL-1 receptor and therefore monepantel is effective against nematodes resistant to other anthelmintic classes.
To je prva biološka funkcija, opisana za Hco-MPTL-1 receptor, zaradi česar je monepantel učinkovit pri glistah, ki so odporne na antihelmintike drugih razredov.
This is the number of injection sites and the total number of syringes (each filled with 0.5ml) needed to administer a volume of 0.5ml per injection site for the patient’s treatment.
Tako dobite število mest injiciranja in skupno število injekcijskih brizg (vsaka je napolnjena z 0,5 ml), potrebnih za zdravljenje bolnika.
This is the number of injection sites and the total number of syringes (each filled with 0.5ml) required for the patient’s treatment.
Tako dobite število mest injiciranja in skupno število injekcijskih brizg (vsaka je napolnjena z 0,5 ml), potrebnih za zdravljenje bolnika.
This is the type of MS where the patient has attacks (relapses) in between periods with no symptoms.
To je oblika multiple skleroze, pri kateri ima bolnik napade (zagone) med obdobji brez simptomov.
This is then adjusted every other day according to the patient’s response to treatment.
Ta odmerek se nato glede na odziv bolnika na zdravljenje prilagaja vsak drugi dan.
This is then followed by 10 mg taken once a day, except in patients weighing less than 60 kg, who should take 5 mg once a day.
Temu sledi 10-miligramski odmerek enkrat na dan, razen pri bolnikih, ki tehtajo manj kot 60 kg, ki morajo vzeti 5 mg enkrat na dan.
This is then followed by a second phase in which 3 mg/kg nivolumab is administered as an intravenous infusion over 60 minutes every 2 weeks.
Zdravljenje se nato nadaljuje z drugo fazo, v kateri bolnik prejema 3 mg/kg nivolumaba v obliki 60-minutne intravenske infuzije vsaka 2 tedna.
This is then followed by maintenance doses of 50 mg every four weeks
Nato sledijo še štirje 50
This is then followed by the FOLFIRI treatment.
Nato sledi zdravljenje s shemo FOLFIRI.
This is then followed by the standard 75 mg dose once
Temu sledi običajni 75-miligramski odmerek enkrat na dan v trajanju najmanj
This is then followed by the standard 75- mg dose once a day for at least four weeks (in ST segment elevation myocardial infarction) or for up to 12 months (in unstable angina or non-Q-wave myocardial infarction).
Temu sledi običajni 75-miligramski odmerek enkrat na dan za najmanj štiri tedne (pri miokardnem infarktu z elevacijo spojnice ST) ali največ 12 mesecev (pri nestabilni angini pektoris ali pri miokardnem infarktu brez zobca Q).